Family · Pharmaceutical analytical standards
Maraviroc
An antiretroviral approved in the United States in 2007, the first CCR5 receptor antagonist: it stops strains of HIV-1 that use this co-receptor from entering cells. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The idea came from genetics: people with two copies of the CCR5-delta32 mutation, who lack a working receptor, are highly protected from HIV and remain healthy.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
